These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12826199)

  • 1. Levetiracetam monotherapy for liver transplant patients with seizures.
    Chabolla DR; Harnois DM; Meschia JF
    Transplant Proc; 2003 Jun; 35(4):1480-1. PubMed ID: 12826199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam for seizures after liver transplantation.
    Glass GA; Stankiewicz J; Mithoefer A; Freeman R; Bergethon PR
    Neurology; 2005 Mar; 64(6):1084-5. PubMed ID: 15781837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation.
    Lin CH; Chen CL; Lin TK; Chen NC; Tsai MH; Chuang YC
    Medicine (Baltimore); 2015 Sep; 94(38):e1350. PubMed ID: 26402799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizures in Pediatric Patients With Liver Transplant and Efficacy of Levetiracetam.
    Kılıç B; Güngör S; Arslan M; Selimoğlu MA; Yılmaz S
    J Child Neurol; 2017 Jul; 32(8):740-745. PubMed ID: 28420301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizures in patients with glioma treated with phenytoin and levetiracetam.
    Merrell RT; Anderson SK; Meyer FB; Lachance DH
    J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
    Karamchandani RR; Fletcher JJ; Pandey AS; Rajajee V
    J Clin Neurosci; 2014 Sep; 21(9):1507-13. PubMed ID: 24919470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Levetiracetam for Epilepsy in Pediatric Liver Transplant Recipients With Posterior Reversible Encephalopathy Syndrome.
    Sezer T; Balcı Sezer O; Özçay F; Akdur A; Torgay A; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):96-98. PubMed ID: 32008507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.
    Floeter AE; McCune JS
    J Oncol Pharm Pract; 2017 Jul; 23(5):344-349. PubMed ID: 27208016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam as monotherapy for seizures in a neonate with acute lymphoblastic leukemia.
    Ledet DS; Wheless JW; Rubnitz JE; Brannon Morris E
    Eur J Paediatr Neurol; 2010 Jan; 14(1):78-9. PubMed ID: 19186085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
    Cotton BA; Kao LS; Kozar R; Holcomb JB
    J Trauma; 2011 Aug; 71(2):375-9. PubMed ID: 21825941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous sclerosis successfully treated with levetiracetam monotherapy: 18 months of follow-up.
    Papacostas SS; Papathanasiou ES; Myrianthopoulou P; Stylianidou G
    Pharm World Sci; 2007 Aug; 29(4):350-2. PubMed ID: 17333500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of levetiracetam in a child with nonconvulsive status epilepticus.
    Alehan F; Ozcay F; Haberal M
    J Child Neurol; 2008 Mar; 23(3):331-3. PubMed ID: 18192652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic effect of levetiracetam on epileptic negative myoclonus.
    Gelisse P; Crespel A; Genton P; Baldy-Moulinier M
    Acta Neurol Scand; 2003 Apr; 107(4):302-3. PubMed ID: 12675706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam for the treatment of neonatal seizures.
    Shoemaker MT; Rotenberg JS
    J Child Neurol; 2007 Jan; 22(1):95-8. PubMed ID: 17608315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
    Dooley M; Plosker GL
    Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin or levetiracetam for seizure prophylaxis in TBI.
    DeDea L
    JAAPA; 2012 Dec; 25(12):11. PubMed ID: 23599996
    [No Abstract]   [Full Text] [Related]  

  • 18. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
    Droz-Perroteau C; Marchal C; Dureau-Pournin C; Lassalle R; Jové J; Robinson P; Lavernhe G; Vespignani H; Moore N; Fourrier-Réglat A;
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1183-9. PubMed ID: 22972760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
    Bansal S; Blalock D; Kebede T; Dean NP; Carpenter JL
    J Neurosurg Pediatr; 2014 Feb; 13(2):209-15. PubMed ID: 24286154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.